Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QL1706 and Lenvatinib in Advanced Penile Squamous Cell Carcinoma
NCT07384416Phase 2Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Apr 2026
- Primary completion
- Feb 2029
- Modality
- Bispecific Antibodies, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of QL1706 in penile squamous cell carcinoma (PSCC), sponsored by Sun Yat-sen University. Started Apr 2026; status: recruiting.
02
Drugs
QL1706
03
Conditions
penile squamous cell carcinoma (PSCC)
Beyond the preview
Go deeper on NCT07384416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07384416.